Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease

dc.creatorBarone E.
dc.creatorTramutola A.
dc.creatorTriani F.
dc.creatorCalcagnini S.
dc.creatorDi Domenico F.
dc.creatorRipoli C.
dc.creatorGaetani S.
dc.creatorGrassi C.
dc.creatorButterfield D.A.
dc.creatorCassano T.
dc.creatorPerluigi M.
dc.date.accessioned2020-09-02T22:12:59Z
dc.date.accessioned2022-11-08T20:18:53Z
dc.date.available2020-09-02T22:12:59Z
dc.date.available2022-11-08T20:18:53Z
dc.date.created2020-09-02T22:12:59Z
dc.date.issued2019
dc.identifier56, 4, 2922-2943
dc.identifier08937648
dc.identifierhttps://hdl.handle.net/20.500.12728/3684
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5142928
dc.languageen
dc.publisherHumana Press Inc.
dc.subjectAlzheimer disease
dc.subjectBiliverdin reductase-A
dc.subjectInsulin resistance
dc.subjectIntranasal
dc.subjectNeuroprotection
dc.subjectamyloid beta protein
dc.subjectbiliverdin reductase A
dc.subjecthuman insulin
dc.subjectinsulin receptor substrate 1
dc.subjectoxidoreductase
dc.subjecttau protein
dc.subjectunclassified drug
dc.subjectbiliverdin reductase
dc.subjectbiological marker
dc.subjectinsulin
dc.subjectinsulin receptor substrate
dc.subjectIrs1 protein, mouse
dc.subjectoxidoreductase
dc.subjectadult
dc.subjectaged
dc.subjectAlzheimer disease
dc.subjectanimal experiment
dc.subjectanimal model
dc.subjectanimal tissue
dc.subjectArticle
dc.subjectcontrolled study
dc.subjectdepression
dc.subjectfrontal cortex
dc.subjecthippocampal CA1 region
dc.subjecthippocampal CA3 region
dc.subjecthippocampus
dc.subjectinsulin resistance
dc.subjectinsulin signaling
dc.subjectlong term memory
dc.subjectlong term potentiation
dc.subjectmale
dc.subjectmouse
dc.subjectneuroprotection
dc.subjectnitrosative stress
dc.subjectnonhuman
dc.subjectoxidative stress
dc.subjectprotein phosphorylation
dc.subjectshort term memory
dc.subjectspatial learning
dc.subjectspatial memory
dc.subjectaging
dc.subjectAlzheimer disease
dc.subjectanimal
dc.subjectanimal behavior
dc.subjectcell line
dc.subjectcomplication
dc.subjectdepression
dc.subjectdrug effect
dc.subjectenzymology
dc.subjectintranasal drug administration
dc.subjectmemory
dc.subjectmemory disorder
dc.subjectmetabolism
dc.subjectpathology
dc.subjectpathophysiology
dc.subjectphenotype
dc.subjectsignal transduction
dc.subjecttransgenic mouse
dc.subjectAdministration, Intranasal
dc.subjectAging
dc.subjectAlzheimer Disease
dc.subjectAnimals
dc.subjectBehavior, Animal
dc.subjectBiomarkers
dc.subjectCell Line
dc.subjectDepression
dc.subjectHippocampus
dc.subjectInsulin
dc.subjectInsulin Receptor Substrate Proteins
dc.subjectInsulin Resistance
dc.subjectLong-Term Potentiation
dc.subjectMale
dc.subjectMemory
dc.subjectMemory Disorders
dc.subjectMice, Transgenic
dc.subjectOxidative Stress
dc.subjectOxidoreductases Acting on CH-CH Group Donors
dc.subjectPhenotype
dc.subjectSignal Transduction
dc.titleBiliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease
dc.typeArticle


Este ítem pertenece a la siguiente institución